The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Autoimmune Diseases Treatment Market Research Report 2025
Synopsis
The global Autoimmune Diseases Treatment market was valued at US$ 118690 million in 2023 and is anticipated to reach US$ 141030 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Diseases Treatment.
Report Scope
The Autoimmune Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Active Biotech
Eli Lilly
AstraZeneca
Lupin
Amgen
Bristol-Myers Squibb
AutoImmune
Pfizer
GlaxoSmithKline
F. Hoffmann-La Roche
Johnson & Johnson
Segment by Type
Blood Transfusion
Supplements
Drugs
Physical Therapy
Other
Segment by Application
Hospital
Medical Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Autoimmune Diseases Treatment market was valued at US$ 118690 million in 2023 and is anticipated to reach US$ 141030 million by 2030, witnessing a CAGR of 2.5% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Autoimmune Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Autoimmune Diseases Treatment.
Report Scope
The Autoimmune Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Autoimmune Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Autoimmune Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott Laboratories
Active Biotech
Eli Lilly
AstraZeneca
Lupin
Amgen
Bristol-Myers Squibb
AutoImmune
Pfizer
GlaxoSmithKline
F. Hoffmann-La Roche
Johnson & Johnson
Segment by Type
Blood Transfusion
Supplements
Drugs
Physical Therapy
Other
Segment by Application
Hospital
Medical Center
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Autoimmune Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Diseases Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood Transfusion
1.2.3 Supplements
1.2.4 Drugs
1.2.5 Physical Therapy
1.2.6 Other
1.3 Market by Application
1.3.1 Global Autoimmune Diseases Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Medical Center
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Diseases Treatment Market Perspective (2019-2030)
2.2 Autoimmune Diseases Treatment Growth Trends by Region
2.2.1 Global Autoimmune Diseases Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Autoimmune Diseases Treatment Historic Market Size by Region (2019-2024)
2.2.3 Autoimmune Diseases Treatment Forecasted Market Size by Region (2025-2030)
2.3 Autoimmune Diseases Treatment Market Dynamics
2.3.1 Autoimmune Diseases Treatment Industry Trends
2.3.2 Autoimmune Diseases Treatment Market Drivers
2.3.3 Autoimmune Diseases Treatment Market Challenges
2.3.4 Autoimmune Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Diseases Treatment Players by Revenue
3.1.1 Global Top Autoimmune Diseases Treatment Players by Revenue (2019-2024)
3.1.2 Global Autoimmune Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Autoimmune Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Diseases Treatment Revenue
3.4 Global Autoimmune Diseases Treatment Market Concentration Ratio
3.4.1 Global Autoimmune Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Diseases Treatment Revenue in 2023
3.5 Autoimmune Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Autoimmune Diseases Treatment Product Solution and Service
3.7 Date of Enter into Autoimmune Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Diseases Treatment Breakdown Data by Type
4.1 Global Autoimmune Diseases Treatment Historic Market Size by Type (2019-2024)
4.2 Global Autoimmune Diseases Treatment Forecasted Market Size by Type (2025-2030)
5 Autoimmune Diseases Treatment Breakdown Data by Application
5.1 Global Autoimmune Diseases Treatment Historic Market Size by Application (2019-2024)
5.2 Global Autoimmune Diseases Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Autoimmune Diseases Treatment Market Size (2019-2030)
6.2 North America Autoimmune Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Autoimmune Diseases Treatment Market Size by Country (2019-2024)
6.4 North America Autoimmune Diseases Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Autoimmune Diseases Treatment Market Size (2019-2030)
7.2 Europe Autoimmune Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Autoimmune Diseases Treatment Market Size by Country (2019-2024)
7.4 Europe Autoimmune Diseases Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Diseases Treatment Market Size (2019-2030)
8.2 Asia-Pacific Autoimmune Diseases Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Autoimmune Diseases Treatment Market Size (2019-2030)
9.2 Latin America Autoimmune Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Autoimmune Diseases Treatment Market Size by Country (2019-2024)
9.4 Latin America Autoimmune Diseases Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Diseases Treatment Market Size (2019-2030)
10.2 Middle East & Africa Autoimmune Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Diseases Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Active Biotech
11.2.1 Active Biotech Company Detail
11.2.2 Active Biotech Business Overview
11.2.3 Active Biotech Autoimmune Diseases Treatment Introduction
11.2.4 Active Biotech Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.2.5 Active Biotech Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Autoimmune Diseases Treatment Introduction
11.3.4 Eli Lilly Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Detail
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Autoimmune Diseases Treatment Introduction
11.4.4 AstraZeneca Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.4.5 AstraZeneca Recent Development
11.5 Lupin
11.5.1 Lupin Company Detail
11.5.2 Lupin Business Overview
11.5.3 Lupin Autoimmune Diseases Treatment Introduction
11.5.4 Lupin Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.5.5 Lupin Recent Development
11.6 Amgen
11.6.1 Amgen Company Detail
11.6.2 Amgen Business Overview
11.6.3 Amgen Autoimmune Diseases Treatment Introduction
11.6.4 Amgen Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.6.5 Amgen Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Autoimmune Diseases Treatment Introduction
11.7.4 Bristol-Myers Squibb Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 AutoImmune
11.8.1 AutoImmune Company Detail
11.8.2 AutoImmune Business Overview
11.8.3 AutoImmune Autoimmune Diseases Treatment Introduction
11.8.4 AutoImmune Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.8.5 AutoImmune Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Autoimmune Diseases Treatment Introduction
11.9.4 Pfizer Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.9.5 Pfizer Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Autoimmune Diseases Treatment Introduction
11.10.4 GlaxoSmithKline Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.10.5 GlaxoSmithKline Recent Development
11.11 F. Hoffmann-La Roche
11.11.1 F. Hoffmann-La Roche Company Detail
11.11.2 F. Hoffmann-La Roche Business Overview
11.11.3 F. Hoffmann-La Roche Autoimmune Diseases Treatment Introduction
11.11.4 F. Hoffmann-La Roche Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.11.5 F. Hoffmann-La Roche Recent Development
11.12 Johnson & Johnson
11.12.1 Johnson & Johnson Company Detail
11.12.2 Johnson & Johnson Business Overview
11.12.3 Johnson & Johnson Autoimmune Diseases Treatment Introduction
11.12.4 Johnson & Johnson Revenue in Autoimmune Diseases Treatment Business (2019-2024)
11.12.5 Johnson & Johnson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Autoimmune Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Blood Transfusion
Table 3. Key Players of Supplements
Table 4. Key Players of Drugs
Table 5. Key Players of Physical Therapy
Table 6. Key Players of Other
Table 7. Global Autoimmune Diseases Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Autoimmune Diseases Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Autoimmune Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Autoimmune Diseases Treatment Market Share by Region (2019-2024)
Table 11. Global Autoimmune Diseases Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Autoimmune Diseases Treatment Market Share by Region (2025-2030)
Table 13. Autoimmune Diseases Treatment Market Trends
Table 14. Autoimmune Diseases Treatment Market Drivers
Table 15. Autoimmune Diseases Treatment Market Challenges
Table 16. Autoimmune Diseases Treatment Market Restraints
Table 17. Global Autoimmune Diseases Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Autoimmune Diseases Treatment Market Share by Players (2019-2024)
Table 19. Global Top Autoimmune Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Diseases Treatment as of 2023)
Table 20. Ranking of Global Top Autoimmune Diseases Treatment Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Autoimmune Diseases Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Autoimmune Diseases Treatment Product Solution and Service
Table 24. Date of Enter into Autoimmune Diseases Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Autoimmune Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Autoimmune Diseases Treatment Revenue Market Share by Type (2019-2024)
Table 28. Global Autoimmune Diseases Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Autoimmune Diseases Treatment Revenue Market Share by Type (2025-2030)
Table 30. Global Autoimmune Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Autoimmune Diseases Treatment Revenue Market Share by Application (2019-2024)
Table 32. Global Autoimmune Diseases Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Autoimmune Diseases Treatment Revenue Market Share by Application (2025-2030)
Table 34. North America Autoimmune Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Autoimmune Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Autoimmune Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Autoimmune Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Autoimmune Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Autoimmune Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Autoimmune Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Autoimmune Diseases Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Autoimmune Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Autoimmune Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Autoimmune Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Autoimmune Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Autoimmune Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 49. Abbott Laboratories Company Detail
Table 50. Abbott Laboratories Business Overview
Table 51. Abbott Laboratories Autoimmune Diseases Treatment Product
Table 52. Abbott Laboratories Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 53. Abbott Laboratories Recent Development
Table 54. Active Biotech Company Detail
Table 55. Active Biotech Business Overview
Table 56. Active Biotech Autoimmune Diseases Treatment Product
Table 57. Active Biotech Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 58. Active Biotech Recent Development
Table 59. Eli Lilly Company Detail
Table 60. Eli Lilly Business Overview
Table 61. Eli Lilly Autoimmune Diseases Treatment Product
Table 62. Eli Lilly Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 63. Eli Lilly Recent Development
Table 64. AstraZeneca Company Detail
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Autoimmune Diseases Treatment Product
Table 67. AstraZeneca Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 68. AstraZeneca Recent Development
Table 69. Lupin Company Detail
Table 70. Lupin Business Overview
Table 71. Lupin Autoimmune Diseases Treatment Product
Table 72. Lupin Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 73. Lupin Recent Development
Table 74. Amgen Company Detail
Table 75. Amgen Business Overview
Table 76. Amgen Autoimmune Diseases Treatment Product
Table 77. Amgen Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 78. Amgen Recent Development
Table 79. Bristol-Myers Squibb Company Detail
Table 80. Bristol-Myers Squibb Business Overview
Table 81. Bristol-Myers Squibb Autoimmune Diseases Treatment Product
Table 82. Bristol-Myers Squibb Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 83. Bristol-Myers Squibb Recent Development
Table 84. AutoImmune Company Detail
Table 85. AutoImmune Business Overview
Table 86. AutoImmune Autoimmune Diseases Treatment Product
Table 87. AutoImmune Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 88. AutoImmune Recent Development
Table 89. Pfizer Company Detail
Table 90. Pfizer Business Overview
Table 91. Pfizer Autoimmune Diseases Treatment Product
Table 92. Pfizer Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 93. Pfizer Recent Development
Table 94. GlaxoSmithKline Company Detail
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Autoimmune Diseases Treatment Product
Table 97. GlaxoSmithKline Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 98. GlaxoSmithKline Recent Development
Table 99. F. Hoffmann-La Roche Company Detail
Table 100. F. Hoffmann-La Roche Business Overview
Table 101. F. Hoffmann-La Roche Autoimmune Diseases Treatment Product
Table 102. F. Hoffmann-La Roche Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 103. F. Hoffmann-La Roche Recent Development
Table 104. Johnson & Johnson Company Detail
Table 105. Johnson & Johnson Business Overview
Table 106. Johnson & Johnson Autoimmune Diseases Treatment Product
Table 107. Johnson & Johnson Revenue in Autoimmune Diseases Treatment Business (2019-2024) & (US$ Million)
Table 108. Johnson & Johnson Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Diseases Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Autoimmune Diseases Treatment Market Share by Type: 2023 VS 2030
Figure 3. Blood Transfusion Features
Figure 4. Supplements Features
Figure 5. Drugs Features
Figure 6. Physical Therapy Features
Figure 7. Other Features
Figure 8. Global Autoimmune Diseases Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Autoimmune Diseases Treatment Market Share by Application: 2023 VS 2030
Figure 10. Hospital Case Studies
Figure 11. Medical Center Case Studies
Figure 12. Other Case Studies
Figure 13. Autoimmune Diseases Treatment Report Years Considered
Figure 14. Global Autoimmune Diseases Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Autoimmune Diseases Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Autoimmune Diseases Treatment Market Share by Region: 2023 VS 2030
Figure 17. Global Autoimmune Diseases Treatment Market Share by Players in 2023
Figure 18. Global Top Autoimmune Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Autoimmune Diseases Treatment as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Autoimmune Diseases Treatment Revenue in 2023
Figure 20. North America Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Autoimmune Diseases Treatment Market Share by Country (2019-2030)
Figure 22. United States Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Autoimmune Diseases Treatment Market Share by Country (2019-2030)
Figure 26. Germany Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Autoimmune Diseases Treatment Market Share by Region (2019-2030)
Figure 34. China Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Autoimmune Diseases Treatment Market Share by Country (2019-2030)
Figure 42. Mexico Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Autoimmune Diseases Treatment Market Share by Country (2019-2030)
Figure 46. Turkey Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Autoimmune Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Abbott Laboratories Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 49. Active Biotech Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 50. Eli Lilly Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 51. AstraZeneca Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 52. Lupin Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 53. Amgen Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 54. Bristol-Myers Squibb Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 55. AutoImmune Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 56. Pfizer Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 59. Johnson & Johnson Revenue Growth Rate in Autoimmune Diseases Treatment Business (2019-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
